Company overview
Phenomenex is a global analytical chemistry leader providing HPLC columns, GC columns, and sample preparation products for pharmaceutical, biopharmaceutical, and biotech research. The company specializes in separation and purification solutions used in drug discovery, development, clinical testing, and quality control. As an operating company within Danaher Corporation's Life Sciences group, Phenomenex serves industrial, clinical, governmental, and academic laboratories worldwide.
HPLC, GC & Sample Prep Solutions is listed in the NovaPharmaNews Supplier Hub as a Lab Equipment & Instruments partner serving United States & Americas. Core focus areas include hplc columns, chromatography solutions, pharmaceutical analysis, sample preparation, drug discovery.
Industry categories: Lab Equipment & Instruments. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.phenomenex.com
- Categories
- Lab Equipment & Instruments
- Markets served
- United States & Americas
- Keywords
- hplc columns, chromatography solutions, pharmaceutical analysis, sample preparation, drug discovery
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What chromatography products does Phenomenex offer?
- Phenomenex manufactures HPLC columns, ultra-high-performance liquid chromatography (UHPLC) columns, gas chromatography (GC) columns, sample preparation products, and chromatography accessories. Their portfolio includes extraction tubes for clinical samples, columns for pharmaceutical purity confirmation, and columns for pesticide testing in food safety applications.
- What industries and applications does Phenomenex serve?
- Phenomenex serves pharmaceutical and biopharmaceutical drug discovery and development, clinical research and diagnostics, food safety and environmental analysis, biotech, and academic laboratories. Their solutions support emerging biologics including mRNA and gene therapy, as well as traditional biologics such as recombinant proteins, monoclonal antibodies, and peptides.
- What is Phenomenex's parent company and market position?
- Phenomenex is an operating company within the Life Sciences group of Danaher Corporation. Founded nearly 40 years ago, the company is recognized as a global technology leader in analytical chemistry with expertise in surface chemistry, polymer and silica particle technology, process chemistry, and novel column packing methods.
Related editorial coverage
- Drug Discovery USA 2026: What to Expect
- Lunai Bioworks and BrainStorm Therapeutics Launch AI Collaboration for Parkinson's and Rare Epilepsy
- Verge Rebrands AI Drug Discovery After Trial Setback
- Streamlined R&D at Novo Nordisk: Insights from Research Chief Petersen
- BBSW AI Solution Event: Daily Roundup
- BBSW AI Solution Event: Biotech Innovation in US
Explore lab tools and QA/QC resources for R&D teams.
